Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 51Neoplasms 29Prostatic Neoplasms 28Head and Neck Neoplasms 15Lung Neoplasms 14Ovarian Neoplasms 9Pancreatic Neoplasms 8Urinary Bladder Neoplasms 6Sarcoma 6Oropharyngeal Neoplasms 6Hematologic Neoplasms 6Gastrointestinal Neoplasms 6Colorectal Neoplasms 6Uterine Cervical Neoplasms 5Rectal Neoplasms 5Neoplasm Metastasis 5Multiple Myeloma 5Esophageal Neoplasms 5Endometrial Neoplasms 5Depression 5Brain Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Polycystic Ovary Syndrome 4Motor Activity 4Melanoma 4Lymphoma 4Anxiety Disorders 4Stomach Neoplasms 3Pain 3Osteosarcoma 3

Interventions

Saline Solution 2Lorazepam 2Haloperidol 2remimazolam 1haloperidol decanoate 1Surveys and Questionnaires 1Propofol 1Ibuprofen 1Dexmedetomidine 1Chlorpromazine 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Delirium × Surveys and Questionnaires × 1 year × Clear all
NCT01949662 2026-02-13

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
93 enrolled 14 charts
Other hematologic neoplasm

Delirium, Hematologic Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡